Persistence of Hepatitis C RNA in Liver Allografts Is Associated with Histologic Progression Independent of Serologic Viral Clearance
Journal of Transplantation · 2009
DOI: 10.1155/2009/297528 ↗Abstract
Background . Hepatitis C virus (HCV) nondetectability in the liver may predict a sustained viral response (SVR) in patients with an end of treatment response. HCV RNA can be detected in liver tissue by in situ hybridization (ISH). Aim . To determine if HCV nondetectability in liver allografts by ISH can predict SVR in patients who cleared virus serologically on treatment. Methods . Twenty five patients with undetectable serum HCV on Interferon/Ribavirin therapy for HCV recurrence post liver transplant (LT) were studied. All had biopsies at 4 months post LT (baseline) and follow up with HCV ISH analysis performed. Results . 10 were ISH positive (group 1); 15 were ISH negative (group 2). Groups 1 and 2 had similar patient, donor, and viral characteristics at LT, as well as treatment duration at the time of the ISH assayed liver biopsy ( 13 ± 16 versus 10 ± 4 months P = .24). However, group 1 had longer total treatment duration ( 24 ± 10 versus 14 ± 5 months, P = .001). Eight (80%) group 1 and 9 (60%) group 2 patients achieved SVR. Mean grade and stage (modified Ishak score) were similar at 4 months, however, group 1 had higher grade ( 3 ± 1.7 versus 1.6 ± 1.3 , P = .039) and stage ( 1.4 ± 1.4 versus 0.5 ± 0.6 , P = .084) on the ISH assayed biopsy, after similar post LT intervals ( 23 ± 10 versus 24 ± 12 months, P = .91). Conclusion . Allograft HCV ISH nondetectability does not predict SVR in treatment responsive HCV recurrence, but is associated with less severe histologic disease.
EUVIMED